alzheimer-disease

Documents about alzheimer-disease

• Biopsychosocial risk factors for Alzheimer’s disease and related dementias in UK immigrants from the Middle East and North Africa (MENA)#424665Europe PMC
• Characterization of [(18)F]SMBT-1 binding substrates in Alzheimer's disease and related disorders: A postmortem biochemical and immunohistochemical study.#469347NCBI PubMed Central
• Integrative machine learning and single-nucleus transcriptomics reveal MAPK-centered neuronal responses underlying the potential Alzheimer's disease risk of GenX.#479508NCBI PubMed Central
• Distinct Filament Conformation for Receptor-Bound Amyloid-β from Alzheimer’s Disease Brain#485029Europe PMC
• EEG recordings during visuo-attentive task reduce sex bias in Alzheimer's disease diagnosis#5449Europe PMC
• Using objective and subjective measures of mind wandering to predict progression to development of cognitive impairment and test associations with Alzheimer disease biomarkers.#135714NCBI PubMed Central
• From brain waves to heartbeats: Exploring the combined role of electroencephalography and heart-rate variability in Alzheimer's disease diagnosis and management.#135767NCBI PubMed Central
• Interpretable multivariate survival models: Improving predictions for conversion from mild cognitive impairment to Alzheimer's disease via data fusion and machine learning.#148080NCBI PubMed Central
• A new era in neuropharmacology: assessing the efficacy and safety of novel anti-amyloid and non-amyloid drug targets for Alzheimer's disease.#159664NCBI PubMed Central
• Addressing the knowledge and recruitment gap in Alzheimer's disease and precision medicine research among Native people: an innovative randomized controlled trial.#160083NCBI PubMed Central
• Caregiver burden and quality of life associated with behavioral and psychological symptoms of Alzheimer's disease: A web-based cross-sectional survey study.#186074NCBI PubMed Central
• Opposing and antagonizing effects of SARS-CoV-2/COVID-19 infection and recombinant zoster vaccination on the risk of late-onset Alzheimer disease#200178bioRxiv / medRxiv
• Effects of 40-Hz transcranial alternating current stimulation on cognition and neural markers in Alzheimer's disease: a randomized, sham-controlled trial.#214208NCBI PubMed Central
• circPDE4B downregulation triggers GEMIN5‑dependent translational stress response and autophagy to reduce MAPT pathology#215368Europe PMC
• Lifestyle shapes preclinical social and microglial deficits in an Alzheimer’s disease mouse model#273107edoc-Server
• MRI detects blood-brain barrier alterations in a rat model of Alzheimer’s disease and lung infection#274370HAL (France)
• Attenuation of blood-brain barrier dysfunction by functionalized gold nanoparticles against amyloid-β peptide in an Alzheimer's disease-on-a-chip model#285905Repositorio Académico de la Universidad de Chile
• Predicting Early Stages Of Alzheimer's Disease And Identifying Key Biomarkers Using Deep Artificial Neural Network And Ensemble Of Machine Learning Methodologies#332548arXiv CS
• Higher physical activity levels mitigate synaptic protein loss and cognitive deterioration in aging and in Alzheimer's disease: a 10-year longitudinal study.#375195NCBI PubMed Central
• Integrating serum pharmacology, network pharmacology, and molecular biology analysis to reveal the mechanisms of Baihe Dihuang decoction in treating Alzheimer's disease.#378504NCBI PubMed Central
• Influence of N-Functionalization of Amiridine on the Biological Activity of Its Conjugates as Multitarget Agents for Potential Treatment of Alzheimer's Disease.#404240NCBI PubMed Central
• NSAID use is associated with lower dementia and Alzheimer disease prevalence and slower cognitive decline: A retrospective longitudinal analysis of the NACC cohort#410913bioRxiv / medRxiv
• Targeting Hippocampal PTEN Suppresses Ferroptosis and Rescues Cognitive Decline in Alzheimer's Disease via Dual AKT/GSK3β/Nrf2 and AKT/STAT3 Axes.#427902NCBI PubMed Central
• APOE and genetic risk variants influence Alzheimer's disease onset in carriers of an extra copy of APP, with and without Down syndrome.#440631NCBI PubMed Central
• Differential Synaptic Loss in β‐Amyloid Positive Versus β‐Amyloid Negative Corticobasal Syndrome#463528Apollo
• CTE-type tau filaments in Alzheimer’s disease with co-morbid LATE-NC#485069Europe PMC
• Sex Hormones in Neurodegenerative Processes and Diseases#486418Directory of Open Access Books
• 42 U.S.C. § 11292 — Education of public, individuals with Alzheimer’s disease and their families, and health and long-term care providers#590080US Code (LII)
• The association between APOE 𝜀4 carrierships and the detection of amyloid positivity using an Alzheimer's disease proteomic blood test in asymptomatic Down syndrome.#3812NCBI PubMed Central
• Cancer and dementia incidence are strongly correlated worldwide: evidence from cross-national regression analyses#5188Europe PMC
• Population-specific polygenic risk for Alzheimer's disease is associated with Mini-Mental State Examination-based cognitive decline in a Japanese cohort#134317bioRxiv / medRxiv
• Repeated presentation of a word list in a consistent order increases differences in total words recalled between those with and without Alzheimer's disease.#165510NCBI PubMed Central
• Using diffusion MRI to relate hippocampal subfield microstructure to delayed verbal memory in cognitively intact individuals at genetic risk for developing Alzheimer's disease.#227727NCBI PubMed Central
• Stratification of brain-derived extracellular vesicles of Alzheimer’s disease patients indicates a unique proteomic content and a higher seeding capacity of small extracellular vesicles#357322HAL (France)
• Implications of autolysosome- astrocyte-associated signature in the pathogenesis of Alzheimer's disease: evidence from artificial intelligence and multi-omics and clinical validation.#378471NCBI PubMed Central
• miR155, triplicated in Down syndrome, regulates the development of neural stem cells and GABAergic interneurons in Alzheimer's disease mouse and human iPSC models.#440632NCBI PubMed Central
• People Living with Dementia and Carers: Financial, Psychological and Physical Health Implications, Interview Transcripts, 2025#447101UK Data Service OAI-PMH Repository (Production)
• Integrated UHPLC-Q-Orbitrap HRMS and Network Pharmacology Approach for Exploring Potential Active Ingredients and Pharmacological Mechanisms of Epimedii Folium Against Alzheimer's Disease.#449709NCBI PubMed Central
• Mapping cross‐domain drivers of Alzheimer's disease risk through integrated network analysis#485229Europe PMC
• Le rôle des représentations sémantiques dans le maintien en mémoire de travail : investigations comportementales et computationnelles chez les jeunes adultes et les personnes âgées, dans le cadre du vieillissement sain et pathologique#161261HAL (France)
• Interventions to support young carers/supporters of people living with dementia: a mixed methods systematic review#4507Europe PMC
• 7-ketocholesterol as a theranostic target: Potential applications and future perspectives#7606HAL (France)
• Local translation controls early reactive changes in perisynaptic astrocyte processes at pre-symptomatic stages of Alzheimer’s disease#138345Unpaywall
• From Cerebrospinal Fluid to Blood Draw: Plasma p-Tau217 as a Non-Invasive Biomarker for Alzheimer's Disease: A Fagan Nomogram-Based Meta-Analytic Study.#154174NCBI PubMed Central
• Exploring Linalool-Based Phytotherapy for Excitatory/Inhibitory Imbalance in Alzheimer's Disease: A Review of Lavender and Cannabis Therapeutic Effects on Sleep, Seizures, and Cognition.#159953NCBI PubMed Central
• FDG-PET imaging to identify brain regions associated with Alzheimer's disease-related TDP-43 proteinopathy: A predictive model using penalized logistic regression analysis.#209713NCBI PubMed Central
• Regulatory Variation at TERT and TERC Shows Limited Association with Early-Onset Alzheimer's Disease in Carriers of the Mexican Founder Mutation PSEN1 A431E.#235926NCBI PubMed Central
• Racial and ethnic differences in the impact of air pollution on the risk of Alzheimer's disease and related dementias in the Multiethnic Cohort Study.#244178NCBI PubMed Central
• Vulnerability of anterior medial temporal lobe subregions to early tau-related neurodegeneration in Alzheimer's disease: Converging evidence from tau-PET and plasma p-tau217.#295060NCBI PubMed Central
• Self-reporting quality of life in mild-to-moderate Alzheimer’s disease and Lewy body dementia: Comparing capability and health-focused measures using response process validation#319336PubMed Central